96: AI in Bioprocess Development: The Game-Changer You Can't Ignore with Belma Alispahic - Part 2

Send us a text

Are you ready to revolutionize your bioprocess development? Join David Brühlmann as he interviews Belma Alispahic, Chief Scientific Officer and Co-Founder of AnalysisMode, who unveils the game-changing potential of AI in biopharma.

Discover how AI is transforming the industry, from drug discovery to manufacturing, and learn why it's no longer optional but essential for success.

Key takeaways:

1. Leverage AI to streamline experiments, reduce costs, and accelerate your path to market
2. Gain insights into emerging AI technologies reshaping biopharma's future
3. Learn practical steps to integrate AI into your workflow, even with limited resources

Don't miss this opportunity to stay ahead of the curve and unlock the full potential of your biotech projects. Tune in now to empower your scientific journey and simplify complex bioprocessing challenges with AI-driven solutions.

Connect with Belma Alispahic:

LinkedIn: https://www.linkedin.com/in/balispahic

Analysis Mode: https://analysismode.com

Next Steps:

Wondering how to develop biologics with clarity and precision? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment

Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? Contact us at https://bruehlmann-consulting.com